May 22, 2013 3:04 PM ET

Biotechnology

Company Overview of ADViSYS, Inc.

Company Overview

ADViSYS, Inc., a biotechnology company, engages in the development and delivery of DNA-based therapies. It develops and commercializes animal applications of growth hormone releasing hormone technology. The company was founded in 1997 and is headquartered in the Woodlands, Texas. As of April 24, 2007, ADViSYS, Inc. operates as a subsidiary of Viral Genomix, Inc.

2700 Research Forest Drive

Suite 180

The Woodlands, TX 77381

United States

Founded in 1997

Phone:

281-296-7300

Fax:

281-296-7333

Key Executives for ADViSYS, Inc.

Co-Founder
Age: 43
Co-Founder and Chairman of Scientific Advisory Board
Chief Financial Officer
Vice President and General Counsel
Chief Medical Officer
Age: 57
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Apthera Inc. United States
Sentinella Pharmaceuticals, Inc. United States
Elekta Inc. United States
Principia Pharmaceuticals Corporation United States
Mintiva Holdings, L.L.C. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADViSYS, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.